日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

From nicotine to SARS-CoV-2 antivirals with potent in vivo efficacy and a broad anti-coronavirus spectrum

从尼古丁到具有强效体内疗效和广谱抗冠状病毒作用的SARS-CoV-2抗病毒药物

Khatua, Kaustav; Atla, Sandeep; Coleman, Demonta; Blankenship, Lauren R; Alugubelli, Yugendar R; Vulupala, Veerabhadra; Guo, Xuejiao Shirley; Xia, Hongjie; Kalveram, Birte K; Walker, David H; Hurst, Brett L; Kumar, Sathish; Cho, Chia-Chuan D; Sharma, Shivangi; Yang, Kai; Rabie, Dorsa; Nyalata, Satyanarayana; Neuman, Benjamin W; Xie, Xuping; Xu, Shiqing; Liu, Wenshe Ray

Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease Inhibitor

发现 EGT710,一种口服非肽模拟可逆共价 SARS-CoV-2 主蛋白酶抑制剂

Papillon, Julien P N; Yuan, Jun; Hesse, Matthew J; Zhang, Lei; Robinson, Richard I; Ware, Nathaniel F; Hornak, Viktor; Karki, Rajeshri G; Kirrane, Tom; Garland, Keira; Joseph, Sajan; Moquin, Stephanie A; Lakshminarayana, Suresh B; Tandeske, Laura; Dovala, Dustin; Knapp, Mark; Ornelas, Elizabeth; Fuller, Daniel; Ho, Pei-I; Xie, Xuping; Vulic, Katarina; Skolnik, Suzanne M; Gao, Jinhai; Zambrowski, Mark; Spiess, Meike; Duca, José S; Busby, Scott A; Schirle, Markus; Robinson, Michael; Shi, Pei-Yong; Moser, Heinz E; Sarko, Christopher; Bradner, James E; Diagana, Thierry T; Tallarico, John A

Neutralization of SARS-CoV-2 by IgM-14 via engagement of two distinct spike epitopes

IgM-14通过与两种不同的刺突蛋白表位结合来中和SARS-CoV-2

Wang, Yan; Hu, Yanping; Ku, Zhiqiang; Yeung, Jason; Zou, Jing; Woodson, Michael; Prokhorov, Nikolai S; Knyazhanskaya, Ekaterina S; Zhao, Haiqing; Sherman, Michael B; An, Zhiqiang; Carroll, Stephen F; Shi, Pei-Yong; Leiman, Petr G; Xie, Xuping

1'- and 4'-Cyano Modified Adenosine Analogs Against Prototypic Flavivirus RNA-Dependent RNA Polymerases

1'-和4'-氰基修饰的腺苷类似物对抗原型黄病毒RNA依赖性RNA聚合酶

Walker, Simon M; Gordon, Calvin J; Tchesnokov, Egor P; Sun, Long; Zou, Jing; Xie, Xuping; Riola, Nicholas C; Cutillas, Vincent; Du Pont, Venice; Zhao, Xiaofeng; Wang, Ting; Pitts, Jared; Siegel, Dustin S; Perry, Jason K; Feng, Joy Y; Bilello, John P; Götte, Matthias

VSA-2-, a novel plant-derived adjuvant for SARS-CoV-2 subunit vaccine

VSA-2,一种新型植物来源的SARS-CoV-2亚单位疫苗佐剂

Adam, Awadalkareem; Lee, Christy; Jones, Madison C; Harrington, Brinley R; Zou, Jing; Peng, Bi-Hung; Xie, Xuping; Wang, Pengfei; Wang, Tian

Intracranial injection of genetically modified, mosquito non-transmissible Zika virus: Safety in primates and ramifications for brain tumor therapy.

脑内注射基因改造的、蚊子无法传播的寨卡病毒:在灵长类动物中的安全性和对脑肿瘤治疗的影响。

Hirsch Alec J, de Andrade Costa Amanda, German Cody, Parkins Christopher J, Smith Jessica L, Russler-Germain Emilie, Kesarwani Ashwani, Li Yuping, Carlson Verginia Cuzon, Carlson Timothy, McBride Jodi L, Srinivasan Sathya, Lewis Anne D, Xie Xuping, Shi Pei-Yong, Diamond Michael S, Chheda Milan G

Mechanistic insights into dengue virus inhibition by a clinical trial compound NITD-688

临床试验化合物 NITD-688 对登革病毒抑制机制的深入研究

Wang, Yan; Sun, Long; Fernandes, Luciana; Wang, Yu-Hsiu; Zou, Jing; Franklin, Samuel J; Hu, Yanping; Palmer, Lee K; Yeung, Jason; Barriga, Daniela; Russell, William K; Moquin, Stephanie A; Shi, Pei-Yong; Skepper, Colin; Xie, Xuping

Druggable genome screens identify SPP as an antiviral host target for multiple flaviviruses.

可药物基因组筛选确定 SPP 是多种黄病毒的抗病毒宿主靶点

Qiao Wenjie, Xie Xuping, Shi Pei-Yong, Ooi Yaw Shin, Carette Jan E

Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial

单价 Omicron KP.2 适应性 BNT162b2 COVID-19 疫苗在成人中的安全性和免疫原性:一项 2/3 期试验的单臂子研究

Diya, Oyeniyi; Gayed, Juleen; Lowry, Francine S; Ma, Hua; Bangad, Vishva; Mensa, Federico; Zou, Jing; Xie, Xuping; Hu, Yanping; Cutler, Mark; Belanger, Todd; Cooper, David; Xu, Xia; Mogg, Robin; Türeci, Özlem; Şahin, Uǧur; Swanson, Kena A; Modjarrad, Kayvon; Anderson, Annaliesa S; Gurtman, Alejandra; Kitchin, Nicholas

Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3.

对 SARS-CoV-2 亚型 BA.2.86、JN.1、KP.2 和 KP.3 的复制和免疫逃避进行比较分析

Hu Yanping, Zou Jing, Nguyen Michael D, Chang Hope C, Yeung Jason, Hao Haiping, Shi Pei-Yong, Ren Ping, Xie Xuping